Skip to main content

Make Bone Health a Priority & Reduce Your Risk of Osteoporosis

Make Bone Health a Priority & Reduce Your Risk of Osteoporosis

Original Air Date : September 20, 2021

Original Air Date : September 20, 2021

Osteoporosis is a disease that takes years to develop without any warning symptoms. Bone mass is gradually lost, making the bones weaker and more prone to fracturing or breaking. The first warning sign of osteoporosis is often a fracture.

Don’t miss our expert panel as they discuss the role of the pharmacist, nutrition and exercise to make bone health a priority and reduce your risk of osteoporosis.


MODERATORS

Cathy Pearcy

Cathy Pearcy

Community Engagement Coordinator

PANELISTS

Shelly Hagen

Shelly Hagen

B.S.H.Ec, RD
Shelly Hagen is a Registered Dietitian and currently works as an Educator in the Women’s Wellness Program at the Grey Nuns Community Hospital in Edmonton, Alberta facilitating menopause and osteoporosis group education sessions, and working one-on-one with patients to make well informed health decisions concerning menopause and osteoporosis management. Shelly completed her Bachelor of Science in Foods and Nutrition at the University of Saskatchewan. She completed a general dietetic internship in Regina and is currently registered with the College of Dietitians of Alberta. Shelly is credentialed as a NAMS Certified Menopause Practitioner (NCMP) through the North American Menopause Society and is also a member of Osteoporosis Canada’s Scientific Advisory Council (SAC).
Teri Charrois

Teri Charrois

BScPharm, ACPR, MSc, EdD
Dr. Teri Charrois is currently the Associate Dean of Practice Innovation and Professor of Teaching at UBC Faculty of Pharmaceutical Sciences. Dr. Charrois graduated with her BScPharm from the University of Alberta (UofA) and then went on to complete an accredited pharmacy residency program followed by working as an internal medicine pharmacist before finishing her master’s degree in clinical epidemiology. In 2014, she joined the UofA Faculty of Pharmacy and Pharmaceutical Sciences as Academic Lead of Practice Innovation. During that time, she completed her Doctor of Education with a focus on adult learning and decision-making. Dr. Charrois was the first pharmacist in the Northern Alberta Osteoporosis Program and provides clinical care in the Multidisciplinary Bone Health Clinic with the Division of Rheumatology at the University of Alberta.
Panagiota (Nota) Klentrou

Panagiota (Nota) Klentrou

PhD, FCSEP
Dr. Klentrou is an internationally recognized exercise and sports physiologist. Her research programme uses applied and basic science approaches to study human performance and the implications of sport training primarily in children and youth. In the last 5 years, she has focused on how sexual maturation, inflammation, adiposity exercise and nutrition affect musculoskeletal growth and development. In particular, this research is trying to identify the cellular mechanisms that explain how exercise training and dietary choices during childhood and adolescence affects skeletal development and lifelong bone health.

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

OC REPLAY WEBINARS – RECENT ITEMS

Cooking Demo Webinar: Egg Tartines

Tartines are open faced sandwiches made with different combinations of ingredients and seasonings to be enjoyed anytime! When cooking for one or two these are perfect and filling for a satisfying meal that you can put together in a matter of minutes. Join Emily Richards, PHEc who will show us how to make three different…

 Biosimilar for Patients on Denosumab

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada. Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab. Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment p…
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001